Another Meta-analysis shows that Long-Acting Beta-Agonists are Safe

Today's article is a continuation of an another article about Long-Acting Beta-Agonists (LABA). I want to highlight an article I read because a mother of a child, who happened to be black, whom I saw just two days ago, had heard that, in his Symbicort inhaler contained something that "killed black folk" and so she did not want him to take any of it. This was a followup visit and needless to say, the boy's symptoms, spirometry, and rescue inhaler use were unchanged. They all indicated poor control.

Physicians around the world continue to examine the safety of LABAs. The latest report, by Jaeschke and others, was published in the American Journal of Respiratory and Critical Care Medicine in September. Briefly, they examined over 29,000 participants of studies (15,710 took a LABA) and concluded that LABA did not increase the risk of death from asthma. This is more comfort for me and I hope those who take LABAs.

If you have questions about your asthma inhaler, please speak with your doctor before you stop using them.